Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Non Operating Income (2023 - 2024)

Kura Oncology (KURA) has disclosed Non Operating Income for 3 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 1.6% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.6 million, a 11.04% increase, with the full-year FY2025 number at $25.3 million, up 18.99% from a year prior.
  • Non Operating Income was $5.3 million for Q4 2025 at Kura Oncology, down from $7.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.5 million in Q1 2025 to a low of $2.5 million in Q1 2023.
  • A 3-year average of $4.7 million and a median of $5.1 million in 2024 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: skyrocketed 97.32% in 2024, then grew 1.6% in 2025.
  • Kura Oncology's Non Operating Income stood at $4.0 million in 2023, then surged by 32.19% to $5.3 million in 2024, then grew by 1.6% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Non Operating Income are $5.3 million (Q4 2025), $7.5 million (Q1 2025), and $5.3 million (Q4 2024).